Cognitive analytic therapy for self-harm in young people Mental and Behavioural Disorders
Conditions
Interventions
The project involves a single therapeutic intervention
The study is a feasibility trial where participants will be randomised using a block design (with random blocks of 4 or 6), stratified by Trust (
Sponsors
Pennine Care NHS Foundation Trust
Eligibility
Sex/Gender
All
Age
13 Years to 17 Years
Inclusion criteria
Inclusion criteria: 1. Aged 13 – 17 years 2. Engaged in self-harm two or more times in their lifetime, with at least one episode in the past year. This will be confirmed via the Self-Injurious Thoughts and Behaviours Interview Short Form (SITBI) 3. Can be safely seen in an outpatient clinical context in which treatment is being provided, as judged by their clinical team or referrer
Exclusion criteria
Exclusion criteria: 1. Moderate-to-severe intellectual disability (IQ:< 70) affecting their eligibility for community mental health services as judged by their clinical team 2. Organic cerebral disease/injury affecting receptive and expressive language comprehension as judged by their clinical team 3. Currently an inpatient 4. Currently experiencing an active episode of mania or psychosis. The MINI International Neuropsychiatric Interview for children and adolescents (MINI-KID) will be used at baseline to screen for the presence of current mania or psychosis 5. Judged at imminent risk of harm to themselves, operationalised as the presence of intent or planning to end their lives within the near future (e.g. next two weeks). In such cases, individuals could still participate once the level of risk has declined 6. Currently receiving another active one-to-one psychological therapy. This would include structured psychological therapies such as CBT or DBT. Other forms of support, like a support group or skills group, seeing a clinician for informal support or medication advice, or engaging with self-help materials, will not exclude people.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The following primary outcome measures were assessed using patient records: 1. Recruitment rates will be recorded across the 12-month recruitment period 2. Participant retention rate (completion of end-of-treatment follow-up assessments) will be recorded over 20 weeks (the length of time in the study) 3. Participant missing data on the proposed primary clinical outcomes (self-harm behaviour and urges) at assessment will be recorded over 20 weeks (the length of time in the study) 4. Adherence to treatment will be recorded as the percentage of participants receiving the minimum dose of therapy (=4 sessions) within the 16-week treatment window | — |
Secondary
| Measure | Time frame |
|---|---|
| The following secondary outcome measures were assessed at the baseline, 8, 16 and 20 week assessments, unless otherwise stated: 1. Self-harm behaviour frequency measured using the Self-Injurious Thoughts and Behaviours Interview-Short Form (SITBI) 2. Urges to self-harm over the past week measured using the Alexian Brothers Urges to Self-Injure Scale (ABUSI) 3. Perceived recovery from mental health difficulties over the past week measured using the Recovery Questionnaire (ReQuestYP) 4. Positive beliefs and perceived dependency on self-harm measured using the Experiences of Self-Injury Questionnaire – Positive Beliefs subscale (ESIQ) 5. Depressive symptoms over the past two weeks measured using the Patient Health Questionnaire – 9 for adolescents (PHQ9A) 6. Difficulties in young people, including internalizing, externalizing and peer problems, measured using the Strengths and Difficulties Questionnaire self-report version (SDQ) 7. Potential adverse experiences that might arise from participation in a psychotherapy trial measured using the Adverse Experiences in Psychotherapy questionnaire (AEP) at 16 weeks only | — |
Countries
England, United Kingdom
Contacts
Public ContactPeter Taylor
Outcome results
None listed